JP2022527569A5 - - Google Patents
Info
- Publication number
- JP2022527569A5 JP2022527569A5 JP2021559455A JP2021559455A JP2022527569A5 JP 2022527569 A5 JP2022527569 A5 JP 2022527569A5 JP 2021559455 A JP2021559455 A JP 2021559455A JP 2021559455 A JP2021559455 A JP 2021559455A JP 2022527569 A5 JP2022527569 A5 JP 2022527569A5
- Authority
- JP
- Japan
- Prior art keywords
- mito
- linker
- group
- targeted ligand
- ligand cluster
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962821628P | 2019-03-21 | 2019-03-21 | |
| US62/821,628 | 2019-03-21 | ||
| US201962952607P | 2019-12-23 | 2019-12-23 | |
| US62/952,607 | 2019-12-23 | ||
| PCT/US2020/023603 WO2020191183A1 (en) | 2019-03-21 | 2020-03-19 | Multivalent ligand clusters for targeted delivery of therapeutic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022527569A JP2022527569A (ja) | 2022-06-02 |
| JP2022527569A5 true JP2022527569A5 (cg-RX-API-DMAC7.html) | 2023-03-28 |
Family
ID=70285946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021559455A Pending JP2022527569A (ja) | 2019-03-21 | 2020-03-19 | 治療剤の標的化送達のための多価リガンドクラスター |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220175934A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3923989A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022527569A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114206389A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020242043A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3133629A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020191183A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230092615A1 (en) | 2020-02-21 | 2023-03-23 | Mitotherapeutix Llc | Compositions and methods for inhibiting expressing of methylation-controlled j-protein (mcj) |
| WO2022109398A1 (en) * | 2020-11-23 | 2022-05-27 | University Of Massachusetts | Oligonucleotides for dgat2 modulation |
| CN115850358B (zh) * | 2021-03-08 | 2026-04-24 | 南京吉迈生物技术有限公司 | GalNAc簇亚磷酰胺和靶向治疗性核苷 |
| PE20250353A1 (es) * | 2021-06-24 | 2025-02-06 | Lilly Co Eli | Terapeutica con arn novedosos y usos de estos |
| PE20250120A1 (es) * | 2021-06-24 | 2025-01-16 | Lilly Co Eli | Restos de administracion terapeutica novedosos y usos de estos |
| KR20240082358A (ko) * | 2021-09-23 | 2024-06-10 | 상하이 아르고 바이오파마슈티칼 씨오., 엘티디. | 치료제의 표적화된 전달을 위한 디아민 스캐폴드를 갖는 다가 리간드 클러스터 |
| KR20240103025A9 (ko) | 2021-11-16 | 2025-12-10 | 상하이 아르고 바이오파마슈티칼 씨오., 엘티디. | 안지오텐시노겐(agt) 단백질의 발현을 저해하는 조성물 및 방법 |
| KR20240111795A (ko) | 2021-11-29 | 2024-07-17 | 상하이 아르고 바이오파마슈티칼 씨오., 엘티디. | B형 간염 바이러스 (hbv) 단백질의 발현을 억제하기 위한 조성물 및 방법 |
| TW202345865A (zh) | 2022-01-24 | 2023-12-01 | 大陸商上海舶望製藥有限公司 | 抑制LPA(Apo(a))蛋白表達的組合物和方法 |
| WO2024104386A1 (zh) * | 2022-11-16 | 2024-05-23 | 南京明德新药研发有限公司 | 一类含七元杂环的三齿缀合基团 |
| CN116535449B (zh) * | 2023-03-22 | 2025-09-16 | 华东理工大学 | 一种糖基没食子酸类衍生物及其制备方法与在制备乳腺癌靶向诊疗材料中的应用 |
| CN116854753B (zh) * | 2023-06-01 | 2025-12-09 | 北京炫景瑞医药科技有限公司 | 一种化合物、缀合物、组合物以及它们的用途 |
| GB202311334D0 (en) * | 2023-07-24 | 2023-09-06 | Astrazeneca Ab | Multivalent cargo-carrying complexes and uses thereof |
| TW202516009A (zh) | 2023-10-10 | 2025-04-16 | 大陸商上海舶望製藥有限公司 | 抑制澱粉樣前體蛋白(app)表達的組合物和方法 |
| WO2026159213A1 (en) * | 2025-01-23 | 2026-07-30 | Astrazeneca Ab | Targeted lipid nanoparticles |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3854480A (en) | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
| US4675189A (en) | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
| US4452775A (en) | 1982-12-03 | 1984-06-05 | Syntex (U.S.A.) Inc. | Cholesterol matrix delivery system for sustained release of macromolecules |
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| US5211657A (en) | 1988-11-07 | 1993-05-18 | The United States Government As Represented By The Secretary Of The Department Of Health And Human Services | Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides |
| US5133974A (en) | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| US5407686A (en) | 1991-11-27 | 1995-04-18 | Sidmak Laboratories, Inc. | Sustained release composition for oral administration of active ingredient |
| US5736152A (en) | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
| PL2992098T3 (pl) * | 2013-05-01 | 2019-09-30 | Ionis Pharmaceuticals, Inc. | Kompozycje i sposoby modulowania ekspresji hbv i ttr |
| JPWO2017111137A1 (ja) * | 2015-12-22 | 2018-10-18 | 味の素株式会社 | オリゴヌクレオチドの製造方法 |
| TWI859114B (zh) * | 2016-04-11 | 2024-10-21 | 加拿大商艾爾布圖斯生技公司 | 靶向組合物 |
| WO2017178656A1 (en) * | 2016-04-14 | 2017-10-19 | Roche Innovation Center Copenhagen A/S | TRITYL-MONO-GalNAc COMPOUNDS AND THEIR USE |
| JOP20170056B1 (ar) * | 2016-09-02 | 2021-08-17 | Arrowhead Pharmaceuticals Inc | مركبات ترابطية مستهدفة |
-
2020
- 2020-03-19 EP EP20719009.1A patent/EP3923989A1/en not_active Withdrawn
- 2020-03-19 CN CN202080037364.0A patent/CN114206389A/zh active Pending
- 2020-03-19 CA CA3133629A patent/CA3133629A1/en active Pending
- 2020-03-19 JP JP2021559455A patent/JP2022527569A/ja active Pending
- 2020-03-19 WO PCT/US2020/023603 patent/WO2020191183A1/en not_active Ceased
- 2020-03-19 US US17/300,676 patent/US20220175934A1/en not_active Abandoned
- 2020-03-19 AU AU2020242043A patent/AU2020242043A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5449769A (en) | Method and reagent for sulfurization of organophosphorous compounds | |
| US5367066A (en) | Oligonucleotides with selectably cleavable and/or abasic sites | |
| US5536821A (en) | Aminoalkylphosphorothioamidate oligonucleotide deratives | |
| JP2022528840A5 (cg-RX-API-DMAC7.html) | ||
| JP2818650B2 (ja) | トリスヒドロキシメチルエタン化合物 | |
| JP2024527542A5 (cg-RX-API-DMAC7.html) | ||
| JP5689054B2 (ja) | Rna化学合成方法 | |
| JP2020522265A5 (cg-RX-API-DMAC7.html) | ||
| JP2019503394A5 (cg-RX-API-DMAC7.html) | ||
| KR20190044653A (ko) | 4'-포스페이트 유사체 및 이를 포함하는 올리고뉴클레오타이드 | |
| KR102375480B1 (ko) | 인 보호기 및 이의 제조 방법 및 용도 | |
| CN103435672A (zh) | 含有取代苄基的新型核苷磷酸酯前药的结构与合成 | |
| JPH07508042A (ja) | 新規2’−0−アルキルヌクレオシドおよびホスホロアミダイトの製造法およびその使用 | |
| JPH05505178A (ja) | オリゴリボヌクレオシド及びオリゴデオキシリボヌクレオシドのボラノフォスフェート | |
| AU2001291540A1 (en) | Linker phosphoramidites for oligonucleotide synthesis | |
| JP5194256B2 (ja) | 2’水酸基修飾リボヌクレオシド誘導体 | |
| JP2011088935A (ja) | リン原子修飾ヌクレオチド類縁体の製造のための光学活性ヌクレオシド3’−ホスホロアミダイト | |
| WO1990008156A1 (fr) | Derives de molecules polyhydroxylees permettant l'introduction d'au moins une ramification dans un oligonucleotide | |
| WO1992006103A1 (en) | Synthesis of oligonucleotides | |
| Yao et al. | Modular Access to P (V)‐Stereogenic Compounds via Cu‐Catalyzed Desymmetrization of (Thio) Phosphonic Dichlorides | |
| Dong et al. | Catalytic construction of P-stereogenic center via phosphorus-centered nucleophilic substitution | |
| Wang et al. | Stereoselective synthesis of P-stereogenic nucleotide prodrugs and oligonucleotides | |
| JP2008502673A5 (cg-RX-API-DMAC7.html) | ||
| CN111393243A (zh) | 一种磷手性核苷类药物的合成方法及该方法得到的药物 | |
| AU642673B2 (en) | Method and reagent for sulfurization of organophosphorous compounds |